NYSEAMERICAN:CRHM - CRH Medical Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $4.38
  • Forecasted Upside: 9.65 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$3.99
+0.30 (1.20%)

This chart shows the closing price for CRHM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CRH Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CRHM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CRHM

Analyst Price Target is $4.38
▲ +9.65% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for CRH Medical in the last 3 months. The average price target is $4.38, with a high forecast of $6.00 and a low forecast of $3.00. The average price target represents a 9.65% upside from the last price of $3.99.

This chart shows the closing price for CRHM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 5 contributing investment analysts is to hold stock in CRH Medical. This rating has held steady since February 2020, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
12/29/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
3/28/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
6/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 4 hold ratings
  • 0 sell ratings
9/24/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 4 hold ratings
  • 0 sell ratings
12/23/2020
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 0 sell ratings
3/23/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings
6/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
2/9/2021Royal Bank of CanadaDowngradeOutperform ➝ Sector Perform
2/9/2021Canaccord GenuityDowngradeBuy ➝ Hold$4.00
2/9/2021National Bank FinancialDowngradeOutperform
1/8/2021Bloom BurtonDowngradeHold$3.00
12/23/2020Bloom BurtonDowngradeBuy ➝ Hold
11/24/2020Acumen CapitalReiterated RatingBuy$6.00
11/16/2020Canaccord GenuityReiterated RatingBuy$4.00
8/13/2020Bloom BurtonReiterated RatingBuy$4.00
8/12/2020Bloom BurtonReiterated RatingBuy
8/12/2020Royal Bank of CanadaBoost Price TargetOutperform$4.00 ➝ $4.50
6/26/2020Canaccord GenuityBoost Price TargetBuy$3.00 ➝ $3.50
5/14/2020Beacon SecuritiesDowngradeBuy ➝ Hold
5/14/2020Royal Bank of CanadaLower Price TargetOutperform$4.75 ➝ $4.00
5/14/2020Canaccord GenuityBoost Price TargetBuy$3.00 ➝ $4.00
3/13/2020Canaccord GenuityLower Price TargetBuy$5.00 ➝ $4.00
3/13/2020Royal Bank of CanadaLower Price TargetOutperform$6.50 ➝ $4.75
8/1/2019Bloom BurtonUpgradeAccumulate ➝ Buy
3/20/2019Clarus SecuritiesReiterated RatingBuy
1/8/2019TD SecuritiesReiterated RatingBuy
7/27/2018TD SecuritiesUpgradeHold ➝ Buy
11/17/2017Morgan StanleyUpgradeEqual Weight ➝ Overweight
8/4/2017Canaccord GenuityLower Price TargetBuy$8.00 ➝ $5.00
8/4/2017National Bank FinancialUpgradeSector Perform ➝ Outperform
7/24/2017ScotiabankUpgradeSector Perform ➝ Sector Outperform
7/21/2017Royal Bank of CanadaUpgradeSector Perform ➝ Outperform
7/18/2017TD SecuritiesDowngradeBuy ➝ Hold
7/17/2017Canaccord GenuityReiterated RatingBuy$8.00
7/17/2017CIBCDowngradeSector Outperform ➝ Sector Perform
7/14/2017Bloom BurtonDowngradeBuy ➝ Accumulate
7/14/2017ScotiabankDowngradeOutperform ➝ Sector Perform
3/27/2017Cantor FitzgeraldReiterated RatingOverweight$8.00 ➝ $10.00
2/24/2017Bloom BurtonDowngradeBuy ➝ Accumulate
1/23/2017Canaccord GenuityBoost Price TargetBuy$5.50 ➝ $7.00
12/2/2016Cantor FitzgeraldInitiated CoverageBuy$7.00
11/28/2016Royal Bank of CanadaUpgradeSector Perform ➝ Outperform$7.00 ➝ $8.50
10/28/2016Bloom BurtonReiterated RatingBuy
10/27/2016Canaccord GenuitySet Price TargetBuy$6.00
10/8/2016Royal Bank of CanadaReiterated RatingOutperform$6.50
9/13/2016CIBCReiterated RatingOutperform
7/11/2016Canaccord GenuityReiterated RatingBuy
6/30/2016Canaccord GenuityReiterated RatingBuy
(Data available from 6/21/2016 forward)
CRH Medical logo
CRH Medical Corporation provides anesthesia services for patients undergoing endoscopic procedures in the United States and Canada. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology to treat various grades of hemorrhoid. The company also distributes CRH O'Regan system, treatment protocols, and operational and marketing expertise as a turnkey package directly to physicians. It serves 70 ambulatory surgical/endoscopy centers in 14 states. The company was formerly known as Medsurge Medical Products Corp. and changed its name to CRH Medical Corporation in April 2006. CRH Medical Corporation was founded in 2000 and is headquartered in Vancouver, Canada.
Read More

Today's Range

Now: $3.99
Low: $3.99
High: $4.00

50 Day Range

MA: $2.62
Low: $2.09
High: $2.95

52 Week Range

Now: $3.99
Low: $1.66
High: $4.01

Volume

388,400 shs

Average Volume

1,043,867 shs

Market Capitalization

$285.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.41

Frequently Asked Questions

What sell-side analysts currently cover shares of CRH Medical?

The following equities research analysts have issued stock ratings on CRH Medical in the last twelve months: Acumen Capital, Bloom Burton, Canaccord Genuity, National Bank Financial, Royal Bank of Canada, TheStreet, and Zacks Investment Research.
View the latest analyst ratings for CRHM.

What is the current price target for CRH Medical?

4 Wall Street analysts have set twelve-month price targets for CRH Medical in the last year. Their average twelve-month price target is $4.38, suggesting a possible upside of 9.6%. Acumen Capital has the highest price target set, predicting CRHM will reach $6.00 in the next twelve months. Bloom Burton has the lowest price target set, forecasting a price of $3.00 for CRH Medical in the next year.
View the latest price targets for CRHM.

What is the current consensus analyst rating for CRH Medical?

CRH Medical currently has 3 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in CRHM, but not buy more shares or sell existing shares.
View the latest ratings for CRHM.

What other companies compete with CRH Medical?

How do I contact CRH Medical's investor relations team?

CRH Medical's physical mailing address is 57B - 999 Canada Place World Trade Center, VANCOUVER, BC V6C 3E1, Canada. The company's listed phone number is +1-604-6331440 and its investor relations email address is [email protected] The official website for CRH Medical is investors.crhsystem.com.